Keppler Brian R, Grady Allen T, Jarstfer Michael B
School of Pharmacy, Division of Medicinal Chemistry and Natural Products, University of North Carolina, Chapel Hill, North Carolina 27599-7360, USA.
J Biol Chem. 2006 Jul 21;281(29):19840-8. doi: 10.1074/jbc.M511067200. Epub 2006 May 19.
Telomerase is a ribonucleoprotein complex that synthesizes the G-rich DNA found at the 3'-ends of linear chromosomes. Human telomerase consists minimally of a catalytic protein (hTERT) and a template-containing RNA (hTR), although other proteins are involved in regulating telomerase activity in vivo. Several chaperone proteins, including hsp90 and p23, have demonstrable roles in establishing telomerase activity both in vitro and in vivo, and previous reports indicate that hsp90 and p23 are required for the reconstitution of telomerase activity from recombinant hTERT and hTR. Here we report that hTERT and hTR associate in the absence of a functional hsp90-p23 heterocomplex. We also report that hsp90 inhibitors geldanamycin and novobiocin inhibit recombinant telomerase even after telomerase is assembled. Inhibition by geldanamycin could be overcome by allowing telomerase to first bind its primer, suggesting a role for hsp90 in loading telomerase onto the telomere. Inhibition by novobiocin could not similarly be overcome but instead resulted in destabilization of the hTERT polypeptide. We propose that the hsp90-p23 complex fine tunes and stabilizes a functional telomerase structure, allowing primer loading and extension.
端粒酶是一种核糖核蛋白复合体,可合成线性染色体3'端富含鸟嘌呤的DNA。人端粒酶至少由一种催化蛋白(hTERT)和一种含模板的RNA(hTR)组成,尽管其他蛋白质在体内参与调节端粒酶活性。包括hsp90和p23在内的几种伴侣蛋白在体外和体内建立端粒酶活性方面都具有明显作用,先前的报道表明,hsp90和p23是重组hTERT和hTR重构端粒酶活性所必需的。在此我们报道,在缺乏功能性hsp90 - p23异源复合体的情况下,hTERT和hTR仍能结合。我们还报道,hsp90抑制剂格尔德霉素和新生霉素即使在端粒酶组装后仍能抑制重组端粒酶。允许端粒酶先结合其引物可克服格尔德霉素的抑制作用,这表明hsp90在将端粒酶加载到端粒上发挥作用。新生霉素的抑制作用不能以类似方式被克服,反而导致hTERT多肽不稳定。我们提出hsp90 - p23复合体微调并稳定功能性端粒酶结构,从而允许引物加载和延伸。